Home/Filings/4/0000897069-23-001044
4//SEC Filing

Priebe Waldemar 4

Accession 0000897069-23-001044

CIK 0001729427other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 5:10 PM ET

Size

28.9 KB

Accession

0000897069-23-001044

Insider Transaction Report

Form 4
Period: 2022-12-06
Transactions
  • Sale

    Common Stock

    2023-03-20$1.08/sh5,000$5,400196,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2022-12-08$2.40/sh5,500$13,200234,605 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-15$1.22/sh5,000$6,100211,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-17$1.13/sh5,000$5,650201,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-22$1.08/sh5,000$5,400186,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-28$1.04/sh10,000$10,400156,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-24$1.08/sh5,000$5,400171,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2022-12-09$2.43/sh2,798$6,799231,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-13$1.30/sh5,000$6,500221,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2022-12-06$2.47/sh5,500$13,585245,605 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-10$1.29/sh5,000$6,450226,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-14$1.35/sh5,000$6,750216,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-16$1.24/sh5,000$6,200206,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-27$1.09/sh5,000$5,450166,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2022-12-07$2.46/sh5,500$13,530240,105 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-23$1.08/sh10,000$10,800176,807 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-03-21$1.10/sh5,000$5,500191,807 total(indirect: See footnote)
Footnotes (1)
  • [F1]Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc.

Documents

1 file

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1
  • filerCIK 0001678516

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:10 PM ET
Size
28.9 KB